Minh Khanh Le

Ms. Minh Khanh Le


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HNHong Thi Thuy Nguyen
Hong Thi Thuy Nguyen
MLMinh Khanh Le
Minh Khanh Le
TTThương Trần
Thương Trần
KNKhanh Ngoc Nguyen
Khanh Ngoc Nguyen
NCNgoc Thi Bich Can
Ngoc Thi Bich Can
CVChi Dung Vu
Chi Dung Vu
Background/Objectives: Children with congenital adrenal hyperplasia (CAH) face significant risks of impaired growth and metabolic disturbances despite standard glucocorticoid therapy. This cross-sectional study aimed to evaluate growth outcomes, nutritional status, and associated factors among children with CAH treated in a Viet-namese tertiary pediatric center. Methods: We assessed 201 children aged 1.1–16.5 years in a tertiary pediatric center in Vietnam for anthropometric parameters, biochemical markers (calcium, phosphate, 25-hydroxyvitamin D), and clinical features. Growth status was evaluated using WHO standards, and bone age was assessed radiographically. Statistical analyses explored associations between growth outcomes and clinical, bio-chemical, and treatment-related factors. Results: Stunting was present in 16.4% of chil-dren, while 53.3% were overweight or obese. Bone age advancement occurred in 51.7% of cases. Vitamin D insufficiency or deficiency was detected in 85.6%, and hypocalcemia in 95% of patients. Overweight/obesity, vitamin D deficiency, and bone age advancement were associated with older age, prolonged corticosteroid therapy, higher androgen levels, and clinical features of treatment imbalance (e.g., Cushingoid appearance, hyperpig-mentation). Female sex was significantly associated with higher rates of stunting. Con-clusions: Growth impairment, nutritional deficiencies, and skeletal maturation dis-turbances are prevalent among children with CAH in Vietnam. Early identification of risk factors and tailored management strategies addressing both endocrine and nutritional health are crucial for optimizing long-term outcomes.

16 June 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HNHong Thi Thuy Nguyen
Hong Thi Thuy Nguyen
MLMinh Khanh Le
Minh Khanh Le
TTThương Trần
Thương Trần
KNKhanh Ngoc Nguyen
Khanh Ngoc Nguyen
NCNgoc Thi Bich Can
Ngoc Thi Bich Can
CVChi Dung Vu
Chi Dung Vu
Background/Objectives: Children with congenital adrenal hyperplasia (CAH) face significant risks of impaired growth and metabolic disturbances despite standard glucocorticoid therapy. This cross-sectional study aimed to evaluate growth outcomes, nutritional status, and associated factors among children with CAH treated in a Vietnamese tertiary pediatric center. Methods: We assessed 201 children aged 1.1–16.5 years in a tertiary pediatric center in Vietnam for anthropometric parameters, biochemical markers (calcium, phosphate, 25-hydroxyvitamin D), and clinical features. Growth status was evaluated using WHO standards, and bone age was assessed radiographically. Statistical analyses explored associations between growth outcomes and clinical, biochemical, and treatment-related factors. Results: Stunting was present in 16.4% of children, while 53.3% were overweight or obese. Bone age advancement occurred in 51.7% of cases. Vitamin D insufficiency or deficiency was detected in 85.6% of patients, and hypocalcemia was present in 85.1%. Overweight/obesity, vitamin D deficiency, and bone age advancement were associated with older age, prolonged corticosteroid therapy, higher androgen levels, and clinical features of treatment imbalance (e.g., Cushingoid appearance, hyperpigmentation). Female sex was significantly associated with higher rates of stunting. Conclusions: Growth impairment, nutritional deficiencies, and skeletal maturation disturbances are prevalent among children with CAH in Vietnam. Early identification of risk factors and the implementation of tailored management strategies that address both endocrine and nutritional health are crucial for optimizing long-term outcomes.